Singapore-based healthcare firm Novena Global Lifecare, Chinese healthcare private equity (PE) firm Sinopharm Capital and investor Cedarlake Capital are coming together to raise a $150-million healthcare-focused fund targeting businesses in Southeast Asia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
